Garnier J, Truchot F, Quero J, Meziere X, Clipet F, Alno N, Frachon X, Delanoue O, Bader G, Lejeune S, Limbour P, De Mello G
Département d'odontologie et de chirurgie buccale, faculté d'odontologie, université de Rennes-I, CHU de Rennes, 2, avenue du Professeur-Léon-Bernard, bâtiment 15, 35043 Rennes cedex, France.
Rev Stomatol Chir Maxillofac. 2007 Nov;108(5):407-10. doi: 10.1016/j.stomax.2006.12.004. Epub 2007 Apr 25.
The aim of this survey was to show that tooth extraction could be performed in patients taking antiplatelet agents. The main indication of antiplatelet agents is to reduce the thrombotic disease.
The authors made a descriptive and retrospective analysis of 52 patients taking antiplatelet agents in their department between February 2003 and January 2005. Two hundred and eighteen tooth extractions were performed. For each extraction, a protocol of local hemostasis (filling, suture, compression) was applied.
Three hemorrhagic sockets were reported out of 218 extractions performed without stopping the antiplatelet agent treatment (1.3%). One patient presented with persistent bleeding out of 52 cases (1.9%). No hemostasis had been performed on this patient; a local hemostasis was performed during surgical revision, which stopped the persistent bleeding.
These results show that the hemorrhagic risk can be controlled by a local hemostasis protocol.
本次调查的目的是表明正在服用抗血小板药物的患者可以进行拔牙手术。抗血小板药物的主要适应证是降低血栓性疾病的风险。
作者对2003年2月至2005年1月期间在其科室服用抗血小板药物的52例患者进行了描述性回顾性分析。共进行了218次拔牙手术。每次拔牙后，均采用局部止血方案（填塞、缝合、压迫）。
在218次拔牙手术中，未停止抗血小板药物治疗的情况下，报告有3例拔牙创出血（1.3%）。52例患者中有1例出现持续性出血（1.9%）。该患者未进行止血处理；在手术修复过程中进行了局部止血，止住了持续性出血。
这些结果表明，通过局部止血方案可以控制出血风险。
Zotero 插件